☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
azacitidine
BMS' Onureg (azacitidine) Receives the US FDA's Approval as Continued Treatment for Acute Myeloid Leukemia
September 2, 2020
Genentech's Venclexta (venetoclax) Receives FDA's Accelerated Approval for Patients with Newly-Diagnosed Acute Myeloid Leukemia (A...
November 22, 2018
Load more...
Back to Home
Modal title
×
Modal body text goes here.